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Purpose of the study
This survey determined the extent to which the herb
Moringa oleifera commonly used for medicinal and
nutritional purposes is being consumed among HIV
positive patients.
Methods
The study was a cross-sectional survey carried out at
Parirenyatwa Hospital Opportunistic Infections Clinic. A
convenience sample of 263 HIV-infected adults was
taken from the Zimbabwe National Antiretroviral Roll-
out Program. Using a previously piloted researcher
administered questionnaire; patients who reported to
the clinic over six months were interviewed about their
use of herbal medicines. The focus was on Moringa olei-
fera use, and included plant part, dosage, prescribers
and the associated medical conditions.
Summary of results
Sixty-eight percent (68%) of the study participants con-
sumed Moringa oleifera. Of these, 81% had already com-
menced antiretroviral drugs. Friends or relatives were
the most common source of a recommendation for use
of the herb (69%). Most (80%) consumed Moringa olei-
fera to boost the immune system. The leaf powder was
mainly used, either alone (41%) or in combination with
the root and/or bark (37%).
Conclusions
Moringa oleifera supplementation is common among
HIV positive people. Because it is frequently prescribed
by non-professionals and taken concomitantly with con-
ventional medicine, it poses a potential risk for herb-
drug interactions. Patient medication history taking
should probe for herbal supplementation and appropri-
ate counselling done. Further experimental investiga-
tions into its effect on drug metabolism and transport
would be useful in improving the clinical outcome of
HIV positive patients on HAART.
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